In a filing, Privia Health Group Inc revealed its Chief Executive Officer Mehrotra Parth unloaded Company’s shares for reported $0.23 million on Apr 30 ’24. In the deal valued at $18.42 per share,12,219 shares were sold. As a result of this transaction, Mehrotra Parth now holds 261,640 shares worth roughly $4.99 million.
Then, Morris Matthew Shawn sold 11,059 shares, generating $203,707 in total proceeds. Upon selling the shares at $18.42, the Director now owns 70,101 shares.
Before that, Mountcastle David sold 2,320 shares. Privia Health Group Inc shares valued at $42,734 were divested by the EVP & Chief Financial Officer at a price of $18.42 per share. As a result of the transaction, Mountcastle David now holds 259,959 shares, worth roughly $4.96 million.
Citigroup initiated its Privia Health Group Inc [PRVA] rating to a Buy in a research note published on April 22, 2024; the price target was $25. A number of analysts have revised their coverage, including Barclays’s analysts, who began to cover the stock in early March with a ‘”an Equal weight”‘ rating. BofA Securities revised its rating on February 22, 2024. It rated PRVA as “a Neutral” which previously was an “a Buy”.
Price Performance Review of PRVA
On Monday, Privia Health Group Inc [NASDAQ:PRVA] saw its stock jump 1.81% to $19.08. Over the last five days, the stock has gained 2.31%. Privia Health Group Inc shares have fallen nearly -17.15% since the year began. Nevertheless, the stocks have fallen -30.44% over the past one year. While a 52-week high of $30.15 was reached on 01/02/24, a 52-week low of $17.54 was recorded on 04/02/24. SMA at 50 days reached $19.61, while 200 days put it at $22.21. A total of 1.02 million shares were traded, compared to the trading of 0.78 million shares in the previous session.
Levels Of Support And Resistance For PRVA Stock
The 24-hour chart illustrates a support level at 18.81, which if violated will result in even more drops to 18.55. On the upside, there is a resistance level at 19.33. A further resistance level may holdings at 19.59. The Relative Strength Index (RSI) on the 14-day chart is 53.87, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.43, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 13.64%. Stochastics %K at 75.13% indicates the stock is a holding.
The most recent change occurred on December 06, 2023 when JMP Securities began covering the stock and recommended ‘”a Mkt outperform”‘ rating along with a $27 price target.
